Marissa Ehringer
Concepts (369)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Nicotinic | 24 | 2021 | 322 | 7.080 |
Why?
| Polymorphism, Single Nucleotide | 36 | 2024 | 2065 | 4.810 |
Why?
| Alcohol Drinking | 16 | 2023 | 749 | 3.000 |
Why?
| Smoking | 22 | 2024 | 1463 | 2.790 |
Why?
| Tobacco Use Disorder | 12 | 2019 | 239 | 2.450 |
Why?
| Alcoholism | 14 | 2023 | 766 | 2.410 |
Why?
| Nerve Tissue Proteins | 11 | 2021 | 567 | 2.120 |
Why?
| Anxiety | 5 | 2023 | 949 | 1.930 |
Why?
| Genetic Predisposition to Disease | 17 | 2024 | 2266 | 1.810 |
Why?
| Motor Activity | 6 | 2021 | 667 | 1.690 |
Why?
| Genome-Wide Association Study | 14 | 2024 | 1337 | 1.630 |
Why?
| Ethanol | 10 | 2017 | 585 | 1.520 |
Why?
| Multigene Family | 4 | 2013 | 198 | 1.140 |
Why?
| Genotype | 15 | 2020 | 1831 | 1.080 |
Why?
| Conduct Disorder | 5 | 2014 | 198 | 1.030 |
Why?
| Behavior, Animal | 5 | 2023 | 490 | 1.020 |
Why?
| Nicotine | 5 | 2023 | 303 | 1.010 |
Why?
| Phenotype | 18 | 2023 | 3050 | 0.970 |
Why?
| Brain | 7 | 2023 | 2618 | 0.950 |
Why?
| Mice, Inbred Strains | 5 | 2023 | 402 | 0.950 |
Why?
| Tobacco Products | 3 | 2024 | 111 | 0.930 |
Why?
| Central Nervous System Depressants | 3 | 2014 | 83 | 0.910 |
Why?
| Physical Conditioning, Animal | 2 | 2018 | 229 | 0.880 |
Why?
| Diazepam | 1 | 2023 | 26 | 0.860 |
Why?
| Genetic Markers | 3 | 2020 | 339 | 0.860 |
Why?
| Receptors, GABA-A | 3 | 2016 | 96 | 0.850 |
Why?
| Anti-Anxiety Agents | 1 | 2023 | 41 | 0.850 |
Why?
| Cultural Diversity | 1 | 2023 | 62 | 0.830 |
Why?
| Gene Frequency | 7 | 2016 | 504 | 0.750 |
Why?
| Genetic Variation | 6 | 2022 | 934 | 0.750 |
Why?
| Substance-Related Disorders | 9 | 2015 | 1011 | 0.730 |
Why?
| Choice Behavior | 3 | 2017 | 164 | 0.690 |
Why?
| Locomotion | 1 | 2021 | 98 | 0.690 |
Why?
| Haplotypes | 7 | 2015 | 471 | 0.680 |
Why?
| Marijuana Abuse | 5 | 2012 | 228 | 0.680 |
Why?
| Genetic Association Studies | 4 | 2016 | 359 | 0.670 |
Why?
| Behavior, Addictive | 1 | 2020 | 81 | 0.660 |
Why?
| Chromosome Mapping | 6 | 2020 | 505 | 0.640 |
Why?
| Transcriptome | 5 | 2023 | 881 | 0.640 |
Why?
| Opioid-Related Disorders | 2 | 2024 | 493 | 0.640 |
Why?
| Parkinson Disease | 1 | 2024 | 451 | 0.600 |
Why?
| Female | 52 | 2023 | 68127 | 0.590 |
Why?
| Students | 1 | 2023 | 573 | 0.580 |
Why?
| Alleles | 5 | 2015 | 845 | 0.570 |
Why?
| Human Genetics | 1 | 2017 | 2 | 0.560 |
Why?
| Humans | 69 | 2024 | 128524 | 0.560 |
Why?
| Sex Characteristics | 4 | 2020 | 727 | 0.560 |
Why?
| Biomedical Research | 1 | 2023 | 646 | 0.560 |
Why?
| Animals | 27 | 2024 | 34501 | 0.560 |
Why?
| Hippocampus | 3 | 2022 | 795 | 0.550 |
Why?
| Male | 52 | 2023 | 62883 | 0.550 |
Why?
| Siblings | 9 | 2011 | 215 | 0.540 |
Why?
| Mice | 19 | 2023 | 16579 | 0.530 |
Why?
| Age of Onset | 7 | 2021 | 493 | 0.530 |
Why?
| Brain-Derived Neurotrophic Factor | 2 | 2014 | 111 | 0.520 |
Why?
| Conscious Sedation | 1 | 2017 | 84 | 0.520 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2016 | 39 | 0.520 |
Why?
| Gastrointestinal Microbiome | 1 | 2023 | 635 | 0.510 |
Why?
| Gene Regulatory Networks | 3 | 2023 | 281 | 0.510 |
Why?
| Microbiota | 1 | 2023 | 720 | 0.500 |
Why?
| Gene Expression Regulation | 3 | 2013 | 2506 | 0.490 |
Why?
| Quantitative Trait Loci | 3 | 2020 | 356 | 0.490 |
Why?
| Neurogenesis | 2 | 2015 | 122 | 0.480 |
Why?
| Physical Exertion | 1 | 2016 | 212 | 0.480 |
Why?
| Running | 3 | 2016 | 228 | 0.470 |
Why?
| Anxiety Disorders | 4 | 2023 | 347 | 0.470 |
Why?
| Adolescent | 34 | 2016 | 20213 | 0.460 |
Why?
| Corpus Striatum | 1 | 2016 | 157 | 0.460 |
Why?
| Taste Perception | 1 | 2014 | 23 | 0.460 |
Why?
| Mice, Inbred C57BL | 10 | 2020 | 5257 | 0.460 |
Why?
| Nicotinic Agonists | 1 | 2015 | 125 | 0.440 |
Why?
| Genetic Testing | 1 | 2016 | 427 | 0.430 |
Why?
| DNA, Intergenic | 1 | 2013 | 24 | 0.430 |
Why?
| Receptors, Opioid, mu | 4 | 2019 | 57 | 0.430 |
Why?
| Neurons | 2 | 2020 | 1448 | 0.430 |
Why?
| Longitudinal Studies | 11 | 2019 | 2697 | 0.420 |
Why?
| Mothers | 1 | 2019 | 728 | 0.410 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2019 | 551 | 0.410 |
Why?
| Social Environment | 5 | 2007 | 290 | 0.410 |
Why?
| Child Behavior Disorders | 2 | 2011 | 134 | 0.410 |
Why?
| Up-Regulation | 1 | 2015 | 826 | 0.400 |
Why?
| Promoter Regions, Genetic | 3 | 2015 | 1199 | 0.400 |
Why?
| 3' Untranslated Regions | 1 | 2013 | 136 | 0.400 |
Why?
| Food Preferences | 1 | 2013 | 112 | 0.400 |
Why?
| Receptors, Oxytocin | 1 | 2012 | 23 | 0.390 |
Why?
| Psychology, Adolescent | 2 | 2009 | 63 | 0.380 |
Why?
| Mental Disorders | 5 | 2020 | 1007 | 0.370 |
Why?
| Species Specificity | 5 | 2023 | 567 | 0.360 |
Why?
| Gene Expression | 3 | 2015 | 1462 | 0.360 |
Why?
| Alcohol-Related Disorders | 2 | 2012 | 115 | 0.340 |
Why?
| Linkage Disequilibrium | 4 | 2013 | 256 | 0.320 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 6 | 2013 | 236 | 0.320 |
Why?
| Receptor, Cannabinoid, CB1 | 1 | 2009 | 40 | 0.320 |
Why?
| Genes, Neoplasm | 1 | 2008 | 20 | 0.310 |
Why?
| Antisocial Personality Disorder | 4 | 2016 | 162 | 0.300 |
Why?
| Exercise | 1 | 2020 | 1937 | 0.300 |
Why?
| Internationality | 2 | 2022 | 148 | 0.300 |
Why?
| Luciferases | 3 | 2013 | 147 | 0.290 |
Why?
| Case-Control Studies | 9 | 2019 | 3326 | 0.280 |
Why?
| Mice, 129 Strain | 2 | 2018 | 80 | 0.280 |
Why?
| Receptors, Cannabinoid | 1 | 2006 | 14 | 0.270 |
Why?
| Impulsive Behavior | 2 | 2007 | 129 | 0.270 |
Why?
| Adult | 27 | 2019 | 35315 | 0.270 |
Why?
| Mice, Knockout | 5 | 2020 | 2752 | 0.260 |
Why?
| Polymorphism, Genetic | 5 | 2013 | 639 | 0.260 |
Why?
| Protein Kinase C | 1 | 2007 | 252 | 0.250 |
Why?
| Analgesics, Opioid | 3 | 2024 | 903 | 0.250 |
Why?
| Exploratory Behavior | 2 | 2021 | 86 | 0.240 |
Why?
| Colorado | 7 | 2020 | 4392 | 0.240 |
Why?
| Multifactorial Inheritance | 2 | 2023 | 149 | 0.230 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 2024 | 16 | 0.230 |
Why?
| Sex Factors | 4 | 2020 | 1949 | 0.220 |
Why?
| Disease Models, Animal | 3 | 2023 | 3943 | 0.220 |
Why?
| Interdisciplinary Research | 1 | 2023 | 26 | 0.210 |
Why?
| Hypnotics and Sedatives | 2 | 2017 | 153 | 0.210 |
Why?
| United Kingdom | 1 | 2024 | 256 | 0.210 |
Why?
| Young Adult | 10 | 2016 | 12320 | 0.210 |
Why?
| Analgesia | 1 | 2024 | 92 | 0.210 |
Why?
| Epistasis, Genetic | 1 | 2023 | 71 | 0.210 |
Why?
| Family | 4 | 2011 | 642 | 0.200 |
Why?
| Analysis of Variance | 2 | 2017 | 1271 | 0.200 |
Why?
| Tobacco Use | 1 | 2022 | 61 | 0.200 |
Why?
| Human Genome Project | 1 | 2002 | 15 | 0.190 |
Why?
| Sequence Analysis, RNA | 2 | 2022 | 428 | 0.190 |
Why?
| Rats | 3 | 2024 | 5168 | 0.190 |
Why?
| Maze Learning | 1 | 2021 | 93 | 0.180 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 2 | 2014 | 74 | 0.180 |
Why?
| Spatial Memory | 1 | 2020 | 21 | 0.180 |
Why?
| Quantitative Trait, Heritable | 1 | 2001 | 119 | 0.170 |
Why?
| Polymerase Chain Reaction | 2 | 2014 | 1019 | 0.170 |
Why?
| Extinction, Psychological | 1 | 2020 | 87 | 0.170 |
Why?
| Dizziness | 2 | 2010 | 80 | 0.170 |
Why?
| Transfection | 2 | 2013 | 895 | 0.160 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 937 | 0.160 |
Why?
| RNA, Messenger | 3 | 2014 | 2674 | 0.160 |
Why?
| Computational Biology | 2 | 2020 | 597 | 0.160 |
Why?
| Repressor Proteins | 1 | 2002 | 400 | 0.160 |
Why?
| Lung Neoplasms | 2 | 2010 | 2323 | 0.160 |
Why?
| Epigenomics | 1 | 2019 | 111 | 0.150 |
Why?
| Mice, Inbred BALB C | 2 | 2020 | 1229 | 0.150 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 421 | 0.150 |
Why?
| Smokers | 1 | 2019 | 137 | 0.150 |
Why?
| Mice, Inbred C3H | 1 | 2018 | 274 | 0.150 |
Why?
| Genetic Loci | 2 | 2022 | 274 | 0.140 |
Why?
| Pulmonary Disease, Chronic Obstructive | 2 | 2019 | 950 | 0.140 |
Why?
| Membrane Proteins | 1 | 2024 | 1108 | 0.140 |
Why?
| Cell Line, Tumor | 2 | 2015 | 3160 | 0.130 |
Why?
| GABA Plasma Membrane Transport Proteins | 1 | 2016 | 5 | 0.130 |
Why?
| Calmodulin-Binding Proteins | 1 | 2016 | 12 | 0.130 |
Why?
| Syntaxin 1 | 1 | 2016 | 14 | 0.130 |
Why?
| Proprotein Convertases | 1 | 2016 | 15 | 0.130 |
Why?
| Sleep | 3 | 2013 | 672 | 0.130 |
Why?
| Receptors, Corticotropin-Releasing Hormone | 1 | 2016 | 27 | 0.130 |
Why?
| Munc18 Proteins | 1 | 2016 | 23 | 0.130 |
Why?
| Brain Chemistry | 2 | 2009 | 116 | 0.130 |
Why?
| Quality Control | 1 | 2016 | 156 | 0.130 |
Why?
| Interviews as Topic | 3 | 2007 | 705 | 0.120 |
Why?
| Potassium Channels | 1 | 2016 | 143 | 0.120 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2016 | 182 | 0.120 |
Why?
| Genomics | 1 | 2020 | 716 | 0.120 |
Why?
| Attention Deficit Disorder with Hyperactivity | 3 | 2011 | 398 | 0.120 |
Why?
| DNA-Binding Proteins | 1 | 2002 | 1415 | 0.120 |
Why?
| Volition | 1 | 2014 | 30 | 0.120 |
Why?
| Body Temperature | 1 | 2015 | 215 | 0.120 |
Why?
| Epigenesis, Genetic | 1 | 2019 | 616 | 0.110 |
Why?
| Saccharin | 1 | 2013 | 5 | 0.110 |
Why?
| Vesicular Monoamine Transport Proteins | 1 | 2013 | 5 | 0.110 |
Why?
| Trans-Activators | 1 | 2016 | 381 | 0.110 |
Why?
| Europe | 3 | 2022 | 362 | 0.110 |
Why?
| Age Factors | 3 | 2017 | 3117 | 0.110 |
Why?
| Sweetening Agents | 1 | 2013 | 38 | 0.110 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 391 | 0.110 |
Why?
| Serotonin | 2 | 2008 | 318 | 0.110 |
Why?
| Cotinine | 1 | 2013 | 75 | 0.110 |
Why?
| Base Sequence | 4 | 2013 | 2134 | 0.100 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2013 | 83 | 0.100 |
Why?
| Schizophrenia | 1 | 2017 | 429 | 0.100 |
Why?
| Adolescent Behavior | 3 | 2014 | 505 | 0.100 |
Why?
| Aging | 2 | 2022 | 1770 | 0.100 |
Why?
| HEK293 Cells | 1 | 2015 | 681 | 0.100 |
Why?
| Reflex, Righting | 1 | 2012 | 10 | 0.100 |
Why?
| Inhalant Abuse | 1 | 2012 | 3 | 0.100 |
Why?
| Peer Group | 1 | 2014 | 225 | 0.100 |
Why?
| Tobacco Smoking | 2 | 2023 | 25 | 0.100 |
Why?
| Twins, Monozygotic | 3 | 2011 | 209 | 0.100 |
Why?
| Twins | 3 | 2010 | 249 | 0.100 |
Why?
| Pedigree | 1 | 2013 | 485 | 0.090 |
Why?
| Comorbidity | 4 | 2011 | 1540 | 0.090 |
Why?
| Residence Characteristics | 1 | 2014 | 324 | 0.090 |
Why?
| Reward | 1 | 2013 | 239 | 0.090 |
Why?
| Software | 1 | 2016 | 610 | 0.090 |
Why?
| Middle Aged | 7 | 2022 | 30893 | 0.090 |
Why?
| Research Design | 1 | 2017 | 1038 | 0.090 |
Why?
| Genetic Linkage | 2 | 2008 | 299 | 0.090 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2010 | 56 | 0.090 |
Why?
| Models, Genetic | 2 | 2010 | 590 | 0.090 |
Why?
| Prevalence | 4 | 2019 | 2549 | 0.090 |
Why?
| Factor Analysis, Statistical | 2 | 2010 | 283 | 0.080 |
Why?
| Data Interpretation, Statistical | 2 | 2010 | 335 | 0.080 |
Why?
| Darkness | 1 | 2009 | 25 | 0.080 |
Why?
| Nuclear Family | 1 | 2009 | 51 | 0.080 |
Why?
| Plasmids | 1 | 2010 | 357 | 0.080 |
Why?
| Alcohol-Induced Disorders, Nervous System | 1 | 2009 | 6 | 0.080 |
Why?
| Socioeconomic Factors | 2 | 2010 | 1197 | 0.080 |
Why?
| Sample Size | 2 | 2022 | 115 | 0.080 |
Why?
| Survival Analysis | 1 | 2012 | 1265 | 0.080 |
Why?
| Receptors, Dopamine D2 | 2 | 2006 | 90 | 0.080 |
Why?
| Chi-Square Distribution | 1 | 2009 | 512 | 0.070 |
Why?
| United States | 6 | 2019 | 13876 | 0.070 |
Why?
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 10 | 0.070 |
Why?
| Depressive Disorder, Major | 2 | 2011 | 347 | 0.070 |
Why?
| Cell Line | 1 | 2013 | 2731 | 0.070 |
Why?
| gamma-Aminobutyric Acid | 1 | 2008 | 158 | 0.070 |
Why?
| Emotions | 1 | 2012 | 533 | 0.070 |
Why?
| Eating | 1 | 2009 | 365 | 0.070 |
Why?
| Pregnancy | 1 | 2019 | 6297 | 0.070 |
Why?
| MicroRNAs | 1 | 2013 | 671 | 0.070 |
Why?
| Marijuana Smoking | 1 | 2010 | 239 | 0.070 |
Why?
| DNA | 2 | 2010 | 1392 | 0.070 |
Why?
| Glutamic Acid | 1 | 2008 | 231 | 0.060 |
Why?
| Psychology, Child | 1 | 2006 | 36 | 0.060 |
Why?
| Receptors, Dopamine D1 | 1 | 2006 | 29 | 0.060 |
Why?
| Self Disclosure | 1 | 2006 | 62 | 0.060 |
Why?
| Internal-External Control | 1 | 2006 | 68 | 0.060 |
Why?
| Biometry | 1 | 2006 | 69 | 0.060 |
Why?
| Cell Differentiation | 1 | 2013 | 1883 | 0.060 |
Why?
| Infant | 1 | 2019 | 8913 | 0.060 |
Why?
| Religion | 1 | 2006 | 68 | 0.060 |
Why?
| Data Collection | 1 | 2008 | 649 | 0.060 |
Why?
| Monoamine Oxidase | 1 | 2005 | 27 | 0.060 |
Why?
| Dopamine | 1 | 2008 | 285 | 0.060 |
Why?
| Linear Models | 1 | 2007 | 816 | 0.060 |
Why?
| Cannabis | 1 | 2012 | 435 | 0.060 |
Why?
| Proportional Hazards Models | 1 | 2007 | 1208 | 0.060 |
Why?
| Smoking Cessation | 1 | 2008 | 408 | 0.060 |
Why?
| Child | 6 | 2015 | 20721 | 0.060 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 756 | 0.050 |
Why?
| Oxycodone | 1 | 2024 | 49 | 0.050 |
Why?
| Motivation | 1 | 2008 | 537 | 0.050 |
Why?
| Cohort Studies | 2 | 2015 | 5369 | 0.050 |
Why?
| RNA | 1 | 2010 | 881 | 0.050 |
Why?
| Receptors, Opioid, kappa | 1 | 2003 | 10 | 0.050 |
Why?
| Mice, Congenic | 1 | 2002 | 22 | 0.050 |
Why?
| Cells, Cultured | 1 | 2010 | 4008 | 0.050 |
Why?
| Sequence Analysis, Protein | 1 | 2002 | 28 | 0.050 |
Why?
| Sampling Studies | 1 | 2002 | 96 | 0.050 |
Why?
| Ataxia | 1 | 2002 | 41 | 0.050 |
Why?
| Avoidance Learning | 1 | 2003 | 66 | 0.050 |
Why?
| Open Reading Frames | 1 | 2002 | 116 | 0.050 |
Why?
| Gene-Environment Interaction | 2 | 2014 | 185 | 0.050 |
Why?
| Phylogeny | 3 | 2000 | 846 | 0.050 |
Why?
| Risk Factors | 2 | 2022 | 9727 | 0.050 |
Why?
| Gene Silencing | 1 | 2002 | 185 | 0.050 |
Why?
| Cyclic AMP | 1 | 2002 | 230 | 0.050 |
Why?
| Exons | 1 | 2002 | 337 | 0.050 |
Why?
| Psychopathology | 1 | 2021 | 51 | 0.050 |
Why?
| Memory, Long-Term | 1 | 2020 | 12 | 0.050 |
Why?
| Nucleic Acid Hybridization | 1 | 2001 | 188 | 0.040 |
Why?
| Mice, Mutant Strains | 1 | 2001 | 292 | 0.040 |
Why?
| Spatial Behavior | 1 | 2020 | 22 | 0.040 |
Why?
| Eukaryotic Cells | 1 | 2000 | 34 | 0.040 |
Why?
| Ascomycota | 1 | 2000 | 31 | 0.040 |
Why?
| Interleukins | 1 | 2022 | 242 | 0.040 |
Why?
| Endoribonucleases | 1 | 2000 | 70 | 0.040 |
Why?
| Korarchaeota | 1 | 2000 | 1 | 0.040 |
Why?
| Fungal Proteins | 1 | 2000 | 129 | 0.040 |
Why?
| RNA, Catalytic | 1 | 2000 | 185 | 0.040 |
Why?
| C-Reactive Protein | 1 | 2022 | 396 | 0.040 |
Why?
| rab4 GTP-Binding Proteins | 1 | 2019 | 9 | 0.040 |
Why?
| Cytochrome P-450 CYP2B6 | 1 | 2019 | 9 | 0.040 |
Why?
| Child Abuse | 1 | 2005 | 516 | 0.040 |
Why?
| Cytochrome P450 Family 2 | 1 | 2019 | 12 | 0.040 |
Why?
| Aryl Hydrocarbon Hydroxylases | 1 | 2019 | 41 | 0.040 |
Why?
| Archaea | 1 | 2000 | 78 | 0.040 |
Why?
| Protein Isoforms | 1 | 2020 | 375 | 0.040 |
Why?
| Twins, Dizygotic | 2 | 2011 | 180 | 0.040 |
Why?
| Interleukin-1 | 1 | 2022 | 961 | 0.040 |
Why?
| Aged | 4 | 2022 | 21971 | 0.040 |
Why?
| Inflammation | 2 | 2022 | 2664 | 0.040 |
Why?
| Surveys and Questionnaires | 4 | 2012 | 5346 | 0.030 |
Why?
| Picrates | 1 | 1996 | 4 | 0.030 |
Why?
| Psychiatric Status Rating Scales | 2 | 2010 | 523 | 0.030 |
Why?
| Risk | 1 | 2019 | 852 | 0.030 |
Why?
| Gram-Positive Bacteria | 1 | 1996 | 45 | 0.030 |
Why?
| Southeastern United States | 1 | 2014 | 34 | 0.030 |
Why?
| Transcription, Genetic | 2 | 2013 | 1398 | 0.030 |
Why?
| Alcoholics | 1 | 2013 | 1 | 0.030 |
Why?
| Aged, 80 and over | 2 | 2019 | 7040 | 0.030 |
Why?
| Gene Ontology | 1 | 2013 | 48 | 0.030 |
Why?
| Enkephalins | 1 | 2013 | 17 | 0.030 |
Why?
| Follow-Up Studies | 1 | 2002 | 4898 | 0.030 |
Why?
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2013 | 9 | 0.030 |
Why?
| Prealbumin | 1 | 2013 | 28 | 0.030 |
Why?
| Mice, Inbred DBA | 2 | 2003 | 182 | 0.030 |
Why?
| Myosins | 1 | 2013 | 133 | 0.020 |
Why?
| Protein Precursors | 1 | 2013 | 126 | 0.020 |
Why?
| Severity of Illness Index | 2 | 2012 | 2736 | 0.020 |
Why?
| Exome | 1 | 2013 | 220 | 0.020 |
Why?
| Adolescent Development | 1 | 2012 | 82 | 0.020 |
Why?
| DNA, Complementary | 2 | 2002 | 267 | 0.020 |
Why?
| Molecular Sequence Data | 3 | 2003 | 2818 | 0.020 |
Why?
| Anxiety, Separation | 1 | 2011 | 16 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2012 | 423 | 0.020 |
Why?
| Pleasure | 1 | 2010 | 20 | 0.020 |
Why?
| Prognosis | 1 | 2019 | 3780 | 0.020 |
Why?
| Tumor Suppressor Proteins | 1 | 2013 | 312 | 0.020 |
Why?
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2011 | 61 | 0.020 |
Why?
| Sensation | 1 | 2010 | 50 | 0.020 |
Why?
| Interview, Psychological | 1 | 2010 | 85 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2017 | 3023 | 0.020 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 485 | 0.020 |
Why?
| NF-kappa B | 1 | 2013 | 651 | 0.020 |
Why?
| Regression Analysis | 1 | 2012 | 983 | 0.020 |
Why?
| Psychological Tests | 1 | 2010 | 131 | 0.020 |
Why?
| Signal Transduction | 1 | 2002 | 4829 | 0.020 |
Why?
| Models, Psychological | 1 | 2011 | 306 | 0.020 |
Why?
| Mouth Mucosa | 1 | 2007 | 89 | 0.020 |
Why?
| Juvenile Delinquency | 1 | 2007 | 109 | 0.020 |
Why?
| Hypoxia | 1 | 2013 | 1031 | 0.020 |
Why?
| Cheek | 1 | 2006 | 16 | 0.020 |
Why?
| Gene Expression Profiling | 1 | 2013 | 1687 | 0.020 |
Why?
| Genome, Human | 1 | 2008 | 392 | 0.020 |
Why?
| Environment | 1 | 2007 | 347 | 0.020 |
Why?
| Confidence Intervals | 1 | 2006 | 318 | 0.020 |
Why?
| Taq Polymerase | 1 | 2004 | 10 | 0.010 |
Why?
| Logistic Models | 1 | 2010 | 1975 | 0.010 |
Why?
| Predictive Value of Tests | 1 | 2010 | 1936 | 0.010 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2003 | 149 | 0.010 |
Why?
| Child Behavior | 1 | 2005 | 236 | 0.010 |
Why?
| Colforsin | 1 | 2002 | 50 | 0.010 |
Why?
| Drug Tolerance | 1 | 2002 | 82 | 0.010 |
Why?
| Isoproterenol | 1 | 2002 | 107 | 0.010 |
Why?
| Adrenergic beta-Agonists | 1 | 2002 | 129 | 0.010 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2002 | 141 | 0.010 |
Why?
| Retrospective Studies | 2 | 2010 | 14460 | 0.010 |
Why?
| Genes, Tumor Suppressor | 1 | 2001 | 86 | 0.010 |
Why?
| Antigens, Surface | 1 | 2001 | 150 | 0.010 |
Why?
| Ribonuclease P | 1 | 2000 | 25 | 0.010 |
Why?
| Consensus Sequence | 1 | 2000 | 72 | 0.010 |
Why?
| Genes, Fungal | 1 | 2000 | 51 | 0.010 |
Why?
| Enzymes | 1 | 2001 | 64 | 0.010 |
Why?
| Ion Channels | 1 | 2001 | 127 | 0.010 |
Why?
| Oncogenes | 1 | 2001 | 109 | 0.010 |
Why?
| DNA, Fungal | 1 | 2000 | 73 | 0.010 |
Why?
| Wyoming | 1 | 2000 | 27 | 0.010 |
Why?
| Sequence Alignment | 1 | 2000 | 330 | 0.010 |
Why?
| DNA, Archaeal | 1 | 2000 | 15 | 0.010 |
Why?
| Postural Balance | 1 | 2002 | 197 | 0.010 |
Why?
| Blotting, Western | 1 | 2002 | 1168 | 0.010 |
Why?
| Catalytic Domain | 1 | 2000 | 217 | 0.010 |
Why?
| Structure-Activity Relationship | 1 | 2000 | 530 | 0.010 |
Why?
| In Situ Hybridization | 1 | 2000 | 292 | 0.010 |
Why?
| Alternative Splicing | 1 | 2001 | 218 | 0.010 |
Why?
| DNA, Bacterial | 1 | 2000 | 324 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 2000 | 402 | 0.010 |
Why?
| RNA, Ribosomal, 16S | 1 | 2000 | 521 | 0.010 |
Why?
| Nucleic Acid Conformation | 1 | 2000 | 706 | 0.010 |
Why?
| Mice, Transgenic | 1 | 2002 | 2069 | 0.010 |
Why?
| Temperature | 1 | 2000 | 625 | 0.010 |
Why?
| Sequence Analysis, DNA | 1 | 2000 | 773 | 0.010 |
Why?
| Evolution, Molecular | 1 | 2000 | 467 | 0.010 |
Why?
| Industrial Waste | 1 | 1996 | 5 | 0.010 |
Why?
| Zebrafish | 1 | 2000 | 464 | 0.010 |
Why?
| Biological Evolution | 1 | 2000 | 426 | 0.010 |
Why?
| Biodegradation, Environmental | 1 | 1996 | 83 | 0.010 |
Why?
| Fatty Acids | 1 | 1996 | 413 | 0.010 |
Why?
| Transcription Factors | 1 | 2001 | 1631 | 0.010 |
Why?
| Time Factors | 1 | 2001 | 6503 | 0.010 |
Why?
| Mutation | 1 | 2000 | 3692 | 0.000 |
Why?
|
|
Ehringer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|